Bank Of America Corp Intercept Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $686,667 - $1.44 Million	-74,882 Reduced 20.19%	295,936 $3.27 Million
Q1 2023 May 12, 2023	SELL	$12.53 - $21.71 $1.97 Million - $3.41 Million	-156,871 Reduced 29.73%	370,818 $4.98 Million
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $981,346 - $1.36 Million	84,526 Added 19.07%	527,689 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1.39 Million - $2.24 Million	113,567 Added 34.46%	443,163 $6.18 Million
Q2 2022 Aug 12, 2022	SELL	$11.23 - $19.59 $1.04 Million - $1.82 Million	-92,844 Reduced 21.98%	329,596 $4.55 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $579,990 - $771,730	43,380 Added 11.44%	422,440 $6.87 Million
Q4 2021 Feb 08, 2022	BUY	$14.28 - $19.53 $2.43 Million - $3.32 Million	170,116 Added 81.42%	379,060 $6.17 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $369,890 - $582,883	-28,475 Reduced 11.99%	208,944 $3.1 Million
Q2 2021 Sep 13, 2021	BUY	$15.46 - $24.5 $3.67 Million - $5.82 Million	237,419 New	237,419 $4.74 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.